Physician profile
John P Hurley
NPI 1164481446
$5,261.85
in general payments reported to CMS, 2019-2025
24 companies · $585 in 2025
The $585 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,325 · 2020: $663 · 2021: $1,067 · 2022: $458 · 2023: $722 · 2024: $442 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,748.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $634.20 | 2019-2022 | |
| Next Science LLC | $597.64 | 2023-2024 | Xperience, Blastx, Surgx |
| Smith+Nephew, INC. | $452.32 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Coblation, Q-Fix |
| Horizon Therapeutics Plc | $440.95 | 2019-2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $369.01 | 2020-2024 | Nuzyra |
| Amgen INC. | $249.98 | 2025 | Krystexxa |
| Integra Lifesciences Corporation | $249.24 | 2019 | |
| Bioventus LLC | $243.49 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Advanced Oxygen Therapy INC. | $236.57 | 2019-2022 | |
| Stryker Corporation | $210.64 | 2019-2020 | |
| Treace Medical Concepts, INC. | $198.69 | 2021-2025 | |
| Orthofix Medical, INC. | $184.15 | 2020-2021 | |
| Triad Life Sciences INC. | $177.96 | 2022 | |
| Abbott Laboratories | $158.59 | 2019-2021 | |
| Medtronic, INC. | $154.50 | 2025 | Inceptiv |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $132.95 | 2021-2022 | |
| Kci USA, INC. | $122.92 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $119.51 | 2021 | |
| Biopoly LLC | $105.00 | 2024 | |
| Melinta Therapeutics, LLC | $98.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $46.77 | 2022-2023 | Seglentis |
| Grt US Holding, INC. | $38.74 | 2022 | |
| Davol INC. | $23.43 | 2023 | |
| Averitas Pharma INC. | $16.47 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hurley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.